Skip to content

    Symphony Q1 FY27 earnings call

    SYMPHONY
    Consumer Durables·4 Aug 2026
    Management Summary

    Symphony Limited delivered a strong Q1 FY27 with consolidated revenue growing 8% YoY to ₹378 crore and EBITDA increasing 26% to ₹48 crore, driven by domestic momentum and robust performance from US and China subsidiaries. Gross margins improved to 49.8%, and the company declared an interim dividend of ₹1 per share. However, raw material cost inflation and geopolitical headwinds are expected to pressure margins in the short term, and CTPL Australia continues to face challenges.

    Highlights

    5
    • Consolidated revenue of ₹378 crore, up 8% YoY.

    • Consolidated EBITDA of ₹48 crore, up 26% YoY from ₹38 crore.

    • Gross margin percentage increased to 49.8%, and EBITDA margin to 12.6%.

    • Bonaire USA revenue grew by 35% with robust profitability, and GSK China revenue grew by 43% and is now debt-free.

    • Interim dividend of ₹1 per share declared, with a total payout of about ₹7 crore.

    Concerns

    4
    • Consolidated PAT declined to ₹40 crore from ₹42 crore (though adjusted PAT was up 23%).

    • Raw material cost inflation and geopolitical situation are expected to impact margins in the short term.

    • CTPL Australia revenue continues to soften, reporting a negative EBITDA of ₹4 crore.

    • Standalone exports from India declined due to geopolitical and shipping disruptions.

    Key financials

    Single quarter

    08 metrics
    1. 01Consolidated Revenue₹378 Cr+8%YoY
    2. 02Consolidated EBITDA₹48 Cr+26%YoY
    3. 03Consolidated PAT₹40 Cr-4.8%YoY
    4. 04Consolidated Gross Margin49.8%
    5. 05Consolidated EBITDA Margin12.6%

    Segment breakdown

    • Bonaire USA₹36 Cr23.8%
    • IMPCO Mexico₹54 Cr35.8%
    • GSK China₹34 Cr22.5%
    • CTPL Australia₹27 Cr17.9%
    Donut· Share of Revenue

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Debt disclosed

    Dividend

    ₹1/share (interim)

    Liquidity

    Cash ₹345 crores

    Treasury stands at ₹345 crore after repaying ₹225 crore in loans and remitting to Australia.

    Guidance & targets

    5
    CategoryTargetPriority
    Profitability
    Margin Impact
    likely to be impacted
    Medium
    Sales
    Mexico Sales Growth
    significant growth
    Medium
    Sales
    USA Sales Growth
    significantly better
    Medium
    Sales
    GSK China & Bonaire USA Momentum
    continue the momentum
    Medium
    Sales
    Secondary Sales (Q2 FY27)
    no secondary sales
    High

    What to watch in Q2 FY27

    5

    Mexico Summer '27 Sales Performance

    Next summer (Q1 FY28)
    CurrentTwo consecutive mild summers (Q1 FY26 & Q1 FY27) impacting sales.
    TargetSignificant growth in sales for summer '27.

    Why it matters

    Mexico is a key international market, and a return to normal, robust summer conditions is crucial for sales recovery and overall international segment growth.

    So, we hope and we expect that the summer of '27, statistically, it will be almost impossible for it to be a mild summer. It should be certainly a fairly robust summer, and the sales should grow significantly.

    Risks & concerns

    4
    RiskSeverity

    Raw material cost inflation

    Costs are still fairly elevated, leading to expected margin pressure in the short term, despite some price hikes.Management acknowledged

    high

    Geopolitical situation and shipping disruptions

    Impacted standalone exports from India and continues to affect the Middle East market.Management acknowledged

    medium

    CTPL Australia continued underperformance

    Revenue continues to soften, and the subsidiary reported negative EBITDA, with no further capital allocation planned.Management acknowledged

    medium

    Seasonal demand volatility (mild summers)

    Mexico experienced two consecutive mild summers, impacting sales, but a robust summer is expected for '27.Management acknowledged

    low

    Q&A highlights

    7

    “almost or in excess of 1/3rd of our top line in India, while general trade constitutes 60%-65%.”

    Provides insight into the growing contribution and profitability of modern trade and e-commerce channels for the company.

    asked by Aditya Bhartia

    2 min read6 chapters

    Detailed Narrative

    01

    Q1 FY27 Consolidated Financial Performance

    Symphony Limited reported a consolidated revenue of ₹378 crore for Q1 FY27, marking an 8% year-on-year growth. Consolidated EBITDA increased by 26% to ₹48 crore from ₹38 crore in the previous year. While reported consolidated PAT was ₹40 crore (down from ₹42 crore), adjusted PAT, excluding one-time items📎, grew by 23% to ₹43 crore. The company achieved a gross margin of 49.8% and an EBITDA margin of 12.6%.

    02

    Domestic Market Momentum and Channel Strategy

    The domestic market, particularly India, demonstrated strong momentum with standalone revenue growing by 15% to ₹241 crore, achieving the second-highest June quarter performance historically. This growth occurred despite a significant inventory overhang from the previous summer. Modern trade and e-commerce channels exhibited robust growth exceeding 100%, now contributing over one-third of India's top line with profitability comparable to general trade. The company is expanding its BISP (Beyond India Summer Products) segment, which contributed ₹179 crore (23%) to standalone TTM revenue and is profitable at the EBITDA level.

    03

    International Subsidiaries: Mixed Performance

    International subsidiaries showed mixed results. Bonaire USA delivered strong performance with a 35% revenue growth to ₹36 crore, achieving an EBITDA of ₹18 crore and PAT of ₹17 crore, driven by new air cooler models and a favorable summer. GSK China also performed well, with revenue growing 43% to ₹34 crore (EBITDA ₹6 crore, PAT ₹5 crore), and is now completely debt-free. Conversely, IMPCO Mexico's revenue declined to ₹54 crore (EBITDA ₹3 crore, PAT ₹1 crore), and CTPL Australia continued to soften, reporting revenue of ₹27 crore and a negative EBITDA of ₹4 crore, with no further capital allocation planned for the latter.

    04

    Margin Outlook and Cost Management

    Despite the improved gross margin percentage, management anticipates short-term margin pressure due to elevated raw material costs and ongoing geopolitical uncertainties. The company has already implemented 7-10% price hikes in segments other than household coolers and expects further increases. However, they acknowledge that not all costs can be passed on, and the extent of margin impact will depend on the normalization of costs and the resolution of geopolitical issues.

    05

    Capital Allocation and Shareholder Returns

    Symphony Limited declared an interim dividend of ₹1 per share, resulting in a total payout of approximately ₹7 crore. The company also focused on debt reduction, with Symphony India repaying approximately ₹225 crore in acquisition and working capital loans. As a result, the treasury balance stands at ₹345 crore. GSK China has become completely debt-free, having repaid all its debt and interest to Symphony India.

    06

    Strategic Derisking and Diversification

    The company's strategic derisking and diversification efforts are yielding results, with the Beyond India Summer Products (BISP) segment contributing almost 48% of consolidated revenue on a trailing 12-month basis. This segment includes large space ventilated air cooling, tabletop fans, water heaters, and exports, which are not dependent on the Indian summer, thereby reducing reliance on seasonal domestic demand.

    This is an AI-generated summary of a publicly available earnings call transcript.